← Back to All Stocks
Pasithea Therapeutics Corp. (KTTA) Analysis
Generated on: 2025-07-16 16:55:25 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 6,931,236 shares
Analysis Values
Current Price
$0.69
Predicted Price
$0.77
Expected Return
9.16%
Confidence Score
0.80
RSI (14)
35.77
MACD
-0.06
Volume
231,591
Float Shares
6,931,236
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
251
KTTA
Pasithea Therapeutics Corp.
9.16%
Price: $0.69
Confidence: 0.80
News
Low Float
Last updated: 2025-07-16 16:55:25
Technical Analysis
RSI: 35.77
MACD: -0.06
Risk Analysis
Volatility
126.49%
Max Drawdown
-89.27%
Beta
1.0
Risk Score
100
Social Sentiment
0
Social Sentiment Score (0-100)
Recent News
Pasithea to commence Phase I/Ib trial of neurofibromatosis type 1 therapy
Clinical Trials Arena - 2025-05-15 11:36
Royal North Shore Hospital in Sydney, Australia, is the initial active clinical trial site.
Reddit Discussions
No recent Reddit discussions found.
Recent SEC Filings
No recent SEC filings found.
